Literature DB >> 2454396

The carboxy terminus of pp60c-src is a regulatory domain and is involved in complex formation with the middle-T antigen of polyomavirus.

S H Cheng1, H Piwnica-Worms, R W Harvey, T M Roberts, A E Smith.   

Abstract

A large number of mutations were introduced into the carboxy-terminal domain of pp60c-src. The level of phosphorylation on Tyr-416 and Tyr-527, the transforming activity (as measured by focus formation on NIH 3T3 cells), kinase activity, and the ability of the mutant pp60c-src to associate with the middle-T antigen of polyomavirus were examined. The results indicate that Tyr-527 is a major carboxy-terminal element responsible for regulating pp60c-src in vivo. A good but not perfect correlation exists between lack of phosphorylation at Tyr-527 and increased phosphorylation at Tyr-416, between elevated phosphorylation on Tyr-416 and activated kinase activity, and between activated kinase activity and transforming activity. Phosphorylation of Tyr-527 was insensitive to the mutation of adjacent residues, indicating that the primary sequence only has a minor role in recognition by kinases or phosphatases which regulate it in vivo. Three mutants which have in common a modified Glu-524 residue were phosphorylated on Tyr-416 and Tyr-527 and were weakly transforming. This suggests that other mechanisms besides complete dephosphorylation of Tyr-527 can lead to increased phosphorylation of Tyr-416 and activation of the transforming activity of pp60c-src. Furthermore, the residues between Asp-518 and Pro-525 were required to form a stable complex with middle-T antigen. The proximity of these sequences to Tyr-527 suggests a model in which middle-T activates pp60c-src by binding directly to this region of the molecular and thereby preventing phosphorylation of Tyr-527. Alternatively, middle-T binding may mediate a conformational change in this region, which in turn induces an alteration in the level of phosphorylation at Tyr-527 and Tyr-416.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2454396      PMCID: PMC363334          DOI: 10.1128/mcb.8.4.1736-1747.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  48 in total

1.  Low level of cellular protein phosphorylation by nontransforming overproduced p60c-src.

Authors:  H Iba; F R Cross; E A Garber; H Hanafusa
Journal:  Mol Cell Biol       Date:  1985-05       Impact factor: 4.272

2.  Characterization of pp60src phosphorylation in vitro in Rous sarcoma virus-transformed cell membranes.

Authors:  M D Resh; R L Erikson
Journal:  Mol Cell Biol       Date:  1985-05       Impact factor: 4.272

3.  Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus.

Authors:  R Mann; R C Mulligan; D Baltimore
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

4.  Local mutagenesis of Rous sarcoma virus: the major sites of tyrosine and serine phosphorylation of pp60src are dispensable for transformation.

Authors:  F R Cross; H Hanafusa
Journal:  Cell       Date:  1983-09       Impact factor: 41.582

5.  Rous sarcoma virus variants that carry the cellular src gene instead of the viral src gene cannot transform chicken embryo fibroblasts.

Authors:  H Iba; T Takeya; F R Cross; T Hanafusa; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

6.  Enhancement of cellular src gene product associated tyrosyl kinase activity following polyoma virus infection and transformation.

Authors:  J B Bolen; C J Thiele; M A Israel; W Yonemoto; L A Lipsich; J S Brugge
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

7.  A short sequence in the p60src N terminus is required for p60src myristylation and membrane association and for cell transformation.

Authors:  F R Cross; E A Garber; D Pellman; H Hanafusa
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

8.  Polyoma virus transforming protein associates with the product of the c-src cellular gene.

Authors:  S A Courtneidge; A E Smith
Journal:  Nature       Date:  1983 Jun 2-8       Impact factor: 49.962

9.  Monoclonal antibodies to Rous sarcoma virus pp60src react with enzymatically active cellular pp60src of avian and mammalian origin.

Authors:  S J Parsons; D J McCarley; C M Ely; D C Benjamin; J T Parsons
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

10.  The complex of polyoma virus middle-T antigen and pp60c-src.

Authors:  S A Courtneidge; A E Smith
Journal:  EMBO J       Date:  1984-03       Impact factor: 11.598

View more
  23 in total

Review 1.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

2.  Stoichiometry of cellular and viral components in the polyomavirus middle-T antigen-tyrosine kinase complex.

Authors:  S H Cheng; P C Espino; J Marshall; R Harvey; A E Smith
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

3.  Selective binding of activated pp60c-src by an immobilized synthetic phosphopeptide modeled on the carboxyl terminus of pp60c-src.

Authors:  R R Roussel; S R Brodeur; D Shalloway; A P Laudano
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

4.  Oncogenes result in genomic alterations that activate a transcriptionally silent, dominantly selectable reporter gene (neo).

Authors:  R E Drews; V T Chan; L E Schnipper
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

Review 5.  Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Authors:  Michele M Fluck; Brian S Schaffhausen
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

6.  Mitosis-specific phosphorylation of polyomavirus middle-sized tumor antigen and its role during cell transformation.

Authors:  L Pérez; A Paasinen; B Schnierle; S Käch; M Senften; K Ballmer-Hofer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

7.  Polyomavirus middle-T antigen associates with the kinase domain of Src-related tyrosine kinases.

Authors:  N M Dunant; M Senften; K Ballmer-Hofer
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

8.  pp60c-src binding to polyomavirus middle T-antigen (MT) requires residues 185 to 210 of the MT sequence.

Authors:  C E Brewster; H R Glover; S M Dilworth
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

9.  Structural differences between repressed and derepressed forms of p60c-src.

Authors:  A MacAuley; J A Cooper
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

10.  Differential pp60c-src activity in well and poorly differentiated human colon carcinomas and cell lines.

Authors:  T K Weber; G Steele; I C Summerhayes
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.